8PTL

human PHOX2B C-terminal domain including the polyA fragment at 278K

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
2	2D 1H-13C HSQC	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
3	3D 1H-13C NOESY aliphatic	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
4	3D 1H-13C NOESY aromatic	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
5	3D 1H-15N NOESY	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
6	3D CBCA(CO)NH	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
7	3D H(CCO)NH	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
8	3D HBHA(CO)NH	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
9	3D HN(CO)CA	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
10	3D HNCA	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
11	3D HNCO	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800
12	3D HNHA	0.5 mM [U-13C; U-15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.05 mM DSS, 0.03 % v/v sodium azide	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	278	Bruker AVANCE NEO 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	800

NMR Refinement
Method	Details	Software
torsion angle dynamics		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	4.1.2	Bruker Biospin
2	chemical shift assignment	NMRFAM-SPARKY		Lee, W.; Tonelli, M.; Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 2015, 31 (8), 1325-1327. DOI: 10.1093/bioinformatics/btu830.
3	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
4	refinement	PROCHECK / PROCHECK-NMR		Laskowski, MacArthur, Smith, Jones, Hutchinson, Morris, Moss and Thornton